Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)

St. Vincent's Hospital Melbourne, Fitzroy

Royal Hobart Hospital, Hobart

NYU Langone Health, New York

New York Presbyterian Hospital - Weill Cornell Medicine, New York

University of Rochester Medical Center, Rochester

Hospital Universitario 12 de Octubre, Madrid

Klinik für Pneumologie, Klinisches Studienzentrum Medizinische Hochschule, Hanover

Mayo Clinic, Jacksonville

Cleveland Clinic Florida, Weston

Hospital Universitario Marqués de Valdecilla, Santander

Norton Pulmonary Specialists, Louisville

The Ohio State University Wexner Medical Center, Columbus

University of Kansas Medical Center, Kansas City

University of Nebraska Medical Center, Omaha

Thoraxklinik-Heidelberg gGmbH, Heidelberg

INTEGRIS Baptist Medical Center, Inc., Oklahoma City

Houston Methodist Hospital, Houston

University of Utah Health, Salt Lake City

Lundquist Institute for Biomedical Innovation at Harbor UCLA, Torrance

Klinik und Poliklinik f. Innere Medizin II Universitätsklinikum Regensburg, Regensburg

Medical Corporation, Santa Barbara

AP-HP Hôpital de Bicêtre, Le Kremlin-Bicêtre

Stanford Health Care, Stanford

University of California, Davis Medical Center, Sacramento

Oregon Health & Science University, Portland

Tufts Medical Center, Boston

Všeobecná fakultní nemocnice v Praze, Prague

DRK Kliniken Berlin, Berlin

Universitaetsklinikum Giessen und Marburg GmbH - Medizinische Klinik IV und V, Giessen

Imperial College Healthcare NHS Trust - Hammersmith Medicines Research Limited, London

Royal Papworth Hospital NHS Foundation Trust, Cambridge